Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| UMC Utrecht | OTHER |
| Leiden University Medical Center | OTHER |
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | OTHER |
Not provided
Not provided
Not provided
Not provided
The current international guidelines for CRC surveillance in IBD recommend as first choice the use of chromoendoscopy, and as an alternative high-definition white light endoscopy (HDWLE) for optimal dysplasia detection, based on data from clinical trials. However, data on the superiority of CE over HDWLE are not consistent in literature. The investigators hypothesize that the better performance of CE in some clinical trials is the result of the associated longer procedural time and the fact that every colon segment is examined twice. Currently, no studies have been published evaluating the dysplastic yield of back-to back HDWLE compared to HDWLE with a single pass or CE in patients with IBD. In the present study, the investigators aim to compare the yield of dysplasia/CRC between 1) regular HDWLE, 2) HDWLE back-to-back, and 3) CE.
The investigators assume based on previous research a yield of 12% using high-definition white light endoscopy and 24% using either chromoendoscopy or high-definition white light endoscopy with a second examination (Imperatore et al 2019). To show non-inferiority of back-to-back HDWLE compared to CE, with a non-inferiority margin of 10% (power 80% and alpha 5%,) a total of 226 patients per group is required.
To demonstrate a superiority of back-to-back HDWLE compared to a regular HDWLE, with a 1:2 allocation ratio of single-pass vs back-to-back , 113 and 226 patients per group are needed to achieve 80% power with an alpha of 5%. Therefore, the investigators will include 226 patients in group back-to-back HDWLE, 226 in group CE, and 113 patients in group regular HDWLE. This amounts to a total of 560 patients. To account for any screen-failures The investigators will include at most 5% (of 560) additional patients until 80% power is reached.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| back-to-back HDWLE | Experimental | Similar to single-pass HDWLE, with a second segmental inspection after the first examination in the same session. Equipment is similar to 1. |
|
| single-pass HDWLE | Active Comparator | Using HD white light, the entire colon is examined for dysplasia and other abnormalities after the caecum is reached. The colonoscope has a high-definition camera and processor. All images are displayed on a high definition monitor for optimal resolution. |
|
| Chromoendoscopy | Active Comparator | After introduction of the endoscope into the colon a dye (methylene blue or 0.3% indigo carmine) will be sprayed through a catheter positioned into the biopsy channel. Per segment, the entire colon is dyed, inspected, and lesions are removed. Equipment is similar to the other two arms. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Back-to-back high-definition white light endoscopy | Procedure | Using HD white light, the entire colon is examined for dysplasia and other abnormalities after the caecum is reached, with a second segmental inspection after the first examination in the same session.The colonoscope has a high-definition camera and processor. All images are displayed on a high definition monitor for optimal resolution. |
| Measure | Description | Time Frame |
|---|---|---|
| detection rate of neoplasia for each technique | During endoscopy |
| Measure | Description | Time Frame |
|---|---|---|
| Number of all lesions for each technique | During endoscopy | |
| Number of dysplastic lesions for each technique | After each endoscopy, within one month after the procedure. | |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Frank Hoentjen, MD PhD | Radboud University Medical Center | Principal Investigator |
| Bas Oldenburg, MD PhD | UMC Utrecht | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Radboudumc | Nijmegen | Gelderland | 6525GA | Netherlands | ||
| Utrecht University Medical Center |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This is a multicenter, non-blinded randomized trial with three parallel arms: back-to-back HDWLE, single-pass HDWLE and CE.
Not provided
Not provided
Not provided
Not provided
|
| single-pass high-definition white light endoscopy | Procedure | Using HD white light, the entire colon is examined for dysplasia and other abnormalities after the caecum is reached. The colonoscope has a high-definition camera and processor. All images are displayed on a high definition monitor for optimal resolution. |
|
| chromoendoscopy | Procedure | After introduction of the endoscope into the colon a dye (methylene blue or indigo carmine) will be sprayed through a catheter positioned into the biopsy channel. Per segment, the entire colon is dyed, inspected, and lesions are removed. Equipment is similar to the other two interventions. |
|
| Kudo classification for each lesion |
| During endoscopy when a lesion is detected |
| Duration | Total endoscopic procedure time and endoscopic procedure time during withdrawal for each technique. | During endoscopy |
| Number of targeted biopsies taken in the different groups. | During endoscopy |
| Percentage of non-interpretable/assessable endoscopies | e.g. insufficient preparation, inflammation | During endoscopy |
| Location of the lesion | During endoscopy |
| Size of the lesion in mm | During endoscopy |
| Utrecht |
| Gelderland |
| 3584CX |
| Netherlands |
| Amsterdam UMC, location AMC | Amsterdam | North Holland | 1105 AZ | Netherlands |
| Leiden University Medical Center | Leiden | South Holland | Netherlands |
| ID | Term |
|---|---|
| D015212 | Inflammatory Bowel Diseases |
| D015179 | Colorectal Neoplasms |
| ID | Term |
|---|---|
| D005759 | Gastroenteritis |
| D005767 | Gastrointestinal Diseases |
| D004066 | Digestive System Diseases |
| D007410 | Intestinal Diseases |
| D007414 | Intestinal Neoplasms |
| D005770 | Gastrointestinal Neoplasms |
| D004067 | Digestive System Neoplasms |
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
| D003108 | Colonic Diseases |
| D012002 | Rectal Diseases |
Not provided
Not provided